Calcium modulation of toxicities due to cisplatin

Metal-Based Drugs

Volumn 5, Issue 2, 1998, Pages 77-81

  Aggarwal, Surinder K ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CISPLATIN; EFFECAL; ERGOCALCIFEROL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MALATE DEHYDROGENASE; OXIDOREDUCTASE; TRIACYLGLYCEROL LIPASE; TUMS; TUMS 500; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; KIDNEY; LIVER; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION;

EID: 0031748263     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/MBD.1998.77     Document Type: Article

References (30)

1. Rosenberg B, Van Camp L, Krigas T. Nature 1965; 205: 698.
2. Hardaker WT, Stone RA, McCoy R. Cancer 1974; 34: 1030.
3. Powis G, Hacker MP. The toxicity of anticancer drugs, New York, Pergamon Press. 1991
4. Moore AS, Rand WM, Berg G, L'Heureux DA and Dennis RA. J Am Vet Assoc. 1994; 205: 441.
5. Aggarwal SK, Fadool JM. Anti-Cancer Drugs 1993; 4: 149.
6. Aggarwal SK, San Antonio JD, Sokhansanj A, Miller C. Anti-Cancer Drugs 1994; 5: 177.
7. Jarve RK, Aggarwal SK. Cancer Chemother Pharmacol 12997; 39: 341.
8. Lelieveld P, Van der Vijgh WJF, Van Velzen D. Eur. J. Cancer Clin. Oncol. 1987; 23: 1147.
9. Van Noorden CJF Butcher RW. J Histochem Cytochem 1984; 32: 998.
10. George JC, Ambadkar RM. J Histochem Cytochem 1963; 11: 420.
11. George JC, Iype PT. Stain Technol 1960; 35: 151.
12. Jonker A, Geerts WJC, Charles R, Lamers WH and Van Noorden CJF. J. Histochem Cytochem 1995; 43: 1027.
13. Jennerwein M, Andrews PA. Drug Metabol Disp 1995; 23: 178.
14. Beaty JA, Jones MM, Ma L. Chem Res Toxicol 1992; 5: 647.
15. Tinker ND, Sharma HL, McAuliffe CA. Qualitative investigation, both in vivo and in vitro, of the metabolites formed by cisplatin and paraplatin inbolbing high performance liquid chromatography analysis. In: Nicolini M, ed. Platinum and other metal coordination compounds in chemotherapy, Boston, Martinus Nijhoff, 1987.pp144-159.
16. Aggarwal SK, Broomhead JA, Fairlie DP, Whitehouse MW. Cancer Chemother Pharmacol 1980; 4: 249.
17. Aggarwal SK. J Histochem Cytochem 1993; 41: 1053.
18. Reed DJ. Mechanisms of chemically induced cell injury and cellular protection mechanismn. In: Hodgson E, Levi PE eds. Introduction to Biochemical Toxicology. Appleton and Lange, Norwalk, CT. 1994; pp 264-295
19. Bogin E, Marom M, Levi Y. Eur J Clin Chem Clin Biochem 1994; 32: 843.
20. Levi J, Jacobs C, Kalman S, McTighe M, Weinder MW. J. Pharmacol. Exp. Ther. 1980; 213: 545.
21. Batzer MA, Aggarwal SK. Cancer Chemother Pharmacol 1986; 17: 209.
22. Zhang JG, Lindup WE. Biochem Pharmacol 1993; 45: 2215.
23. Bompart G. Toxicol Lett 1989; 48: 193.
24. Bompart G, Orfila C, Manuel Y. Nephron 1991; 58: 68.
25. Vermeulen NP, Baldew GS. Biochem Pharmacol 1992; 44: 1193.
26. Tyler D. The mitochondrion in health and disease, New York, VCH Publishers, Inc. 1992.
27. Van Rensburg CE, Van Staden AM, Anderson R. Cancer Res 1993; 53: 318.
28. Nishio K, Sugimoto Y, Fujiwara Y, Ohmori T, Morikage T, Takeda Y, Ohata M, Saijo M. J Clin. Invest 1992; 89: 1622.
29. Hahn KH, Waggoner AS, Taylor DL. J Biol Chem 1990; 265: 203.
30. Timbrell JA. Principles of Biochemical Toxicology, 2nd ed. London, Taylor & Francis. 1991